171 related articles for article (PubMed ID: 38551716)
1. Role of albumin infusion in cirrhosis-associated complications.
Heybe MA; Mehta KJ
Clin Exp Med; 2024 Mar; 24(1):58. PubMed ID: 38551716
[TBL] [Abstract][Full Text] [Related]
2. Albumin administration in patients with cirrhosis: Current role and novel perspectives.
de Mattos ÂZ; Simonetto DA; Terra C; Farias AQ; Bittencourt PL; Pase THS; Toazza MR; de Mattos AA;
World J Gastroenterol; 2022 Sep; 28(33):4773-4786. PubMed ID: 36156923
[TBL] [Abstract][Full Text] [Related]
3. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
4. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
[TBL] [Abstract][Full Text] [Related]
5. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
6. [News for usage of albumin in patients with liver disease].
Cremonese C; Uschner FE; Trebicka J
Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
[TBL] [Abstract][Full Text] [Related]
7. Role of albumin in the treatment of decompensated liver cirrhosis.
Trebicka J
Curr Opin Gastroenterol; 2022 May; 38(3):200-205. PubMed ID: 35275900
[TBL] [Abstract][Full Text] [Related]
8. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.
Zheng X; Bai Z; Wang T; Romeiro FG; Mancuso A; Philips CA; Wong YJ; Nery FG; Qi X
Adv Ther; 2023 Apr; 40(4):1494-1529. PubMed ID: 36697778
[TBL] [Abstract][Full Text] [Related]
9. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
10. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
11. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
[TBL] [Abstract][Full Text] [Related]
12. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.
Grüngreiff K; Gottstein T; Reinhold D; Blindauer CA
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836265
[TBL] [Abstract][Full Text] [Related]
13. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
14. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
[TBL] [Abstract][Full Text] [Related]
15. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.
Simonetti RG; Perricone G; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004039. PubMed ID: 31251387
[TBL] [Abstract][Full Text] [Related]
16. Clinical indications for the albumin use: still a controversial issue.
Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
[TBL] [Abstract][Full Text] [Related]
17. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour.
Laffi G; Gentilini P; Romanelli RG; La Villa G
Dig Liver Dis; 2003 Sep; 35(9):660-3. PubMed ID: 14563190
[TBL] [Abstract][Full Text] [Related]
18. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
19. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
[TBL] [Abstract][Full Text] [Related]
20. Long-term albumin infusion in decompensated cirrhosis: A review of current literature.
Wong YJ; Kumar R; Chua YJJ; Ang TL
World J Hepatol; 2021 Apr; 13(4):421-432. PubMed ID: 33959225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
